Bristol Myers Squibb (BMY) EBITDA Margin (2009 - 2026)
Bristol Myers Squibb's EBITDA Margin was 24.19% in Q3 2026, down 9.56 percentage points from 33.75% a year earlier and down 11.88 percentage points from the prior quarter.
Bristol Myers Squibb (BMY) EBITDA Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Bristol Myers Squibb's EBITDA Margin was 28.23% through Sep 30, 2026, up 1.27 percentage points year-over-year; for FY2025, it came in at 27.68%, up 25.15 percentage points from FY2024.
- EBITDA Margin shows a five-year change of +19.42 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 2.53% in FY2024 (-37.91 pp), 40.44% in FY2023 (+1.47 pp), 38.97% in FY2022 (-1.52 pp) and 40.50% in FY2021 (+32.24 pp).
- Quarterly EBITDA Margin has moved between -75.72% (Q1 2024) and 45.86% (Q1 2023) over five years.
- Compared with a year earlier, EBITDA Margin was higher in three of the last eight quarters, with an average year-over-year change of +10.65 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q1 2025 (a gain of 111.28 percentage points); the worst was Q1 2024 (a drop of 121.58 percentage points).
- Per Business Quant data, BMY's EBITDA Margin in the three quarters before Q3 2026 was 36.07% (Q2 2026), 33.36% (Q1 2026) and 19.57% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 42.49% |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | 24.19% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 24.19% |
| Jun 30, 2026 | 36.07% |
| Mar 31, 2026 | 33.36% |
| Dec 31, 2025 | 19.57% |
| Sep 30, 2025 | 33.75% |
| Jun 30, 2025 | 22.69% |
| Mar 31, 2025 | 35.56% |
| Dec 31, 2024 | 16.65% |
| Sep 30, 2024 | 35.89% |
| Jun 30, 2024 | 31.82% |
| Mar 31, 2024 | -75.72% |
| Dec 31, 2023 | 36.05% |
| Sep 30, 2023 | 41.69% |
| Jun 30, 2023 | 38.22% |
| Mar 31, 2023 | 45.86% |
| Dec 31, 2022 | 38.40% |
| Sep 30, 2022 | 42.76% |
| Jun 30, 2022 | 38.20% |
| Mar 31, 2022 | 36.67% |
| Dec 31, 2021 | 37.02% |
Bristol Myers Squibb EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();